Related Experiment Videos
Use of area under the curve to estimate absolute bioavailability of digoxin
Journal of Pharmaceutical Sciences
|January 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetic profile of recombinant human N-acetylgalactosamine 4-sulphatase enzyme replacement therapy in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): a phase I/II study.
Acta paediatrica (Oslo, Norway : 1992). Supplement·2005
Median effect analysis of efficacy versus adverse effects of immunosuppressants.
Clinical pharmacology and therapeutics·2001
Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure.
Journal of clinical pharmacology·1998
The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
The American journal of medicine·1998
Quantitation of interference in digoxin immunoassay in renal, hepatic, and diabetic disease.
Clinical pharmacology and therapeutics·1997
Pharmacodynamics of torsemide administered as an intravenous injection and as a continuous infusion to patients with congestive heart failure.
Journal of clinical pharmacology·1996
Ocular microdialysis in preclinical pharmacokinetic studies: Principles, challenges, and practical insights.
Journal of pharmaceutical sciences·2026
The shake-test for adjuvanted vaccines: A manufacturer's perspective.
Journal of pharmaceutical sciences·2026
At-line estimation of powder lubrication using rotating drum: Linking specific volume kinetics to tensile strength loss.
Journal of pharmaceutical sciences·2026
A novel approach to unified compaction curve model for improved tabletability prediction of virtual roller compacted formulations.
Journal of pharmaceutical sciences·2026
Bridging the divide between health economics and outcomes research and biomedical investment: reflections from a health economist working in venture capital.
Journal of comparative effectiveness research·2026
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026